Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Preimplantation Genetics Diagnosis (PGD) market report explains the definition, types, applications, major countries, and major players of the Preimplantation Genetics Diagnosis (PGD) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Illumina
Genea Limited
Agilent Technologies
F Hoffmann-La Roche
Quest Diagnostics Incorporated
Cooper Surgical
Abbott Laboratories
Thermo Fisher Scientific
Laboratory Corporation of America Holdings
Beijing Genomics Institute (BGI)
Natera Inc
PerkinElmer
By Type:
Gender Selection
Chromosomal Abnormalities
Single Gene Disorders
HLA Typing
Aneuploidy
X-Linked Diseases
Other
By End-User:
Hospitals
Clinics
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Preimplantation Genetics Diagnosis (PGD) Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Preimplantation Genetics Diagnosis (PGD) Outlook to 2028- Original Forecasts
-
2.2 Preimplantation Genetics Diagnosis (PGD) Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Preimplantation Genetics Diagnosis (PGD) Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Preimplantation Genetics Diagnosis (PGD) Market- Recent Developments
-
6.1 Preimplantation Genetics Diagnosis (PGD) Market News and Developments
-
6.2 Preimplantation Genetics Diagnosis (PGD) Market Deals Landscape
7 Preimplantation Genetics Diagnosis (PGD) Raw Materials and Cost Structure Analysis
-
7.1 Preimplantation Genetics Diagnosis (PGD) Key Raw Materials
-
7.2 Preimplantation Genetics Diagnosis (PGD) Price Trend of Key Raw Materials
-
7.3 Preimplantation Genetics Diagnosis (PGD) Key Suppliers of Raw Materials
-
7.4 Preimplantation Genetics Diagnosis (PGD) Market Concentration Rate of Raw Materials
-
7.5 Preimplantation Genetics Diagnosis (PGD) Cost Structure Analysis
-
7.5.1 Preimplantation Genetics Diagnosis (PGD) Raw Materials Analysis
-
7.5.2 Preimplantation Genetics Diagnosis (PGD) Labor Cost Analysis
-
7.5.3 Preimplantation Genetics Diagnosis (PGD) Manufacturing Expenses Analysis
8 Global Preimplantation Genetics Diagnosis (PGD) Import and Export Analysis (Top 10 Countries)
-
8.1 Global Preimplantation Genetics Diagnosis (PGD) Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Preimplantation Genetics Diagnosis (PGD) Export by Region (Top 10 Countries) (2017-2028)
9 Global Preimplantation Genetics Diagnosis (PGD) Market Outlook by Types and Applications to 2022
-
9.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Gender Selection Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chromosomal Abnormalities Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Single Gene Disorders Consumption and Growth Rate (2017-2022)
-
9.1.4 Global HLA Typing Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Aneuploidy Consumption and Growth Rate (2017-2022)
-
9.1.6 Global X-Linked Diseases Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Preimplantation Genetics Diagnosis (PGD) Market Analysis and Outlook till 2022
-
10.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.2.2 Canada Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.2.3 Mexico Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.2 UK Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.3 Spain Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.4 Belgium Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.5 France Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.6 Italy Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.7 Denmark Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.8 Finland Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.9 Norway Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.10 Sweden Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.11 Poland Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.12 Russia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.3.13 Turkey Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.2 Japan Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.3 India Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.4 South Korea Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.5 Pakistan Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.6 Bangladesh Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.7 Indonesia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.8 Thailand Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.9 Singapore Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.10 Malaysia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.11 Philippines Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.4.12 Vietnam Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.2 Colombia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.3 Chile Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.4 Argentina Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.5 Venezuela Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.6 Peru Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.7 Puerto Rico Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.5.8 Ecuador Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6.2 Kuwait Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6.3 Oman Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6.4 Qatar Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6.5 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.6.6 United Arab Emirates Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.7.2 South Africa Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.7.3 Egypt Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.7.4 Algeria Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
-
10.8.2 New Zealand Preimplantation Genetics Diagnosis (PGD) Consumption (2017-2022)
11 Global Preimplantation Genetics Diagnosis (PGD) Competitive Analysis
-
11.1 Illumina
-
11.1.1 Illumina Company Details
-
11.1.2 Illumina Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Illumina Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.1.4 Illumina Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Genea Limited
-
11.2.1 Genea Limited Company Details
-
11.2.2 Genea Limited Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Genea Limited Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.2.4 Genea Limited Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Agilent Technologies
-
11.3.1 Agilent Technologies Company Details
-
11.3.2 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.3.4 Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 F Hoffmann-La Roche
-
11.4.1 F Hoffmann-La Roche Company Details
-
11.4.2 F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.4.4 F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Quest Diagnostics Incorporated
-
11.5.1 Quest Diagnostics Incorporated Company Details
-
11.5.2 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.5.4 Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Cooper Surgical
-
11.6.1 Cooper Surgical Company Details
-
11.6.2 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.6.4 Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Abbott Laboratories
-
11.7.1 Abbott Laboratories Company Details
-
11.7.2 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.7.4 Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Thermo Fisher Scientific
-
11.8.1 Thermo Fisher Scientific Company Details
-
11.8.2 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.8.4 Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Laboratory Corporation of America Holdings
-
11.9.1 Laboratory Corporation of America Holdings Company Details
-
11.9.2 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.9.4 Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Beijing Genomics Institute (BGI)
-
11.10.1 Beijing Genomics Institute (BGI) Company Details
-
11.10.2 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.10.4 Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Natera Inc
-
11.11.1 Natera Inc Company Details
-
11.11.2 Natera Inc Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Natera Inc Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.11.4 Natera Inc Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 PerkinElmer
-
11.12.1 PerkinElmer Company Details
-
11.12.2 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
11.12.4 PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
11.12.5 Recent Research and Development Strategies
12 Global Preimplantation Genetics Diagnosis (PGD) Market Outlook by Types and Applications to 2028
-
12.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Gender Selection Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Chromosomal Abnormalities Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Single Gene Disorders Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global HLA Typing Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Aneuploidy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global X-Linked Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Preimplantation Genetics Diagnosis (PGD) Market Analysis and Outlook to 2028
-
13.1 Global Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.2.2 Canada Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.2.3 Mexico Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.2 UK Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.3 Spain Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.4 Belgium Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.5 France Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.6 Italy Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.7 Denmark Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.8 Finland Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.9 Norway Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.10 Sweden Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.11 Poland Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.12 Russia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.3.13 Turkey Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.2 Japan Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.3 India Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.4 South Korea Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.8 Thailand Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.9 Singapore Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.11 Philippines Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.2 Colombia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.3 Chile Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.4 Argentina Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.6 Peru Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6.3 Oman Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6.4 Qatar Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.7.2 South Africa Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.7.3 Egypt Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.7.4 Algeria Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Preimplantation Genetics Diagnosis (PGD) Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Preimplantation Genetics Diagnosis (PGD)
-
Figure of Preimplantation Genetics Diagnosis (PGD) Picture
-
Table Global Preimplantation Genetics Diagnosis (PGD) Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Preimplantation Genetics Diagnosis (PGD) Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Gender Selection Consumption and Growth Rate (2017-2022)
-
Figure Global Chromosomal Abnormalities Consumption and Growth Rate (2017-2022)
-
Figure Global Single Gene Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global HLA Typing Consumption and Growth Rate (2017-2022)
-
Figure Global Aneuploidy Consumption and Growth Rate (2017-2022)
-
Figure Global X-Linked Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Table North America Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure United States Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Canada Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Mexico Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table Europe Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure Germany Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure UK Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Spain Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Belgium Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure France Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Italy Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Denmark Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Finland Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Norway Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Sweden Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Poland Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Russia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Turkey Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table APAC Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure China Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Japan Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure India Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure South Korea Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Thailand Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Singapore Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Philippines Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table South America Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure Brazil Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Colombia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Chile Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Argentina Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Peru Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table GCC Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure Bahrain Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Oman Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Qatar Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table Africa Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure Nigeria Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure South Africa Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Egypt Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure Algeria Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table Oceania Preimplantation Genetics Diagnosis (PGD) Consumption by Country (2017-2022)
-
Figure Australia Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Preimplantation Genetics Diagnosis (PGD) Consumption and Growth Rate (2017-2022)
-
Table Illumina Company Details
-
Table Illumina Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumina Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Illumina Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Genea Limited Company Details
-
Table Genea Limited Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genea Limited Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Genea Limited Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Agilent Technologies Company Details
-
Table Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Agilent Technologies Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table F Hoffmann-La Roche Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Quest Diagnostics Incorporated Company Details
-
Table Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Quest Diagnostics Incorporated Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Cooper Surgical Company Details
-
Table Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Cooper Surgical Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Abbott Laboratories Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Thermo Fisher Scientific Company Details
-
Table Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Thermo Fisher Scientific Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Laboratory Corporation of America Holdings Company Details
-
Table Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Laboratory Corporation of America Holdings Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Beijing Genomics Institute (BGI) Company Details
-
Table Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Beijing Genomics Institute (BGI) Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table Natera Inc Company Details
-
Table Natera Inc Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natera Inc Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table Natera Inc Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Table PerkinElmer Company Details
-
Table PerkinElmer Preimplantation Genetics Diagnosis (PGD) Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Preimplantation Genetics Diagnosis (PGD) Main Business and Markets Served
-
Table PerkinElmer Preimplantation Genetics Diagnosis (PGD) Product Portfolio
-
Figure Global Gender Selection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chromosomal Abnormalities Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Single Gene Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HLA Typing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aneuploidy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global X-Linked Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Table North America Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure United States Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure Germany Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure China Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure Brazil Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Preimplantation Genetics Diagnosis (PGD) Consumption Forecast by Country (2022-2028)
-
Figure Australia Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Preimplantation Genetics Diagnosis (PGD) Consumption Forecast and Growth Rate (2022-2028)
-
